By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Chineham
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708


SEARCH JOBS


Industry
Pharmaceutical






Company News
New Shire (SHPGY) Research To Be Presented At World Congress On ADHD Highlights Treatment Portfolio, Pipeline And Caregiver Experiences 5/26/2015 9:26:01 AM
New Shire (SHPGY) Research To Be Presented At World Congress On ADHD Highlights Treatment Portfolio, Pipeline And Caregiver Experiences 5/26/2015 8:02:05 AM
LCS Group Announces Exclusive License From Lucerne Biosciences To Commercialize '813 Patent And '249 Application Through Shire (SHPGY)'s Marketing Of Lisdexamfetamine Dimesylate For Binge Eating Disorder 5/14/2015 6:33:29 AM
Shire (SHPGY) To Present New Research At American Psychiatric Association Annual Meeting 5/11/2015 12:36:05 PM
Shire (SHPGY) To Participate At The Deutsche Bank (DB) 40th Annual Healthcare Conference 5/7/2015 12:03:20 PM
Shire (SHPGY) And Foundation Fighting Blindness Announce New Research Agreement 5/4/2015 11:12:14 AM
Shire (SHPGY) Delivers Strong Revenue Growth And Cash Generation; 20% Increase In Non GAAP Earnings Per ADS 5/1/2015 9:06:17 AM
Jeff Poulton Appointed Shire (SHPGY) Chief Financial Officer And Joins Board Of Directors 4/30/2015 6:28:54 AM
Shire (SHPGY) Release: FDA Grants Priority Review To Lifitegrast NDA For The Treatment Of Dry Eye Disease In Adults 4/10/2015 10:40:41 AM
Shire (SHPGY) Reports Topline Results From First Of Three Placebo-Controlled Phase 2 Studies Of SHP625 (LUM001) In Children With Alagille Syndrome 4/9/2015 6:52:26 AM
12345678910...
//-->